Jardiance 10 mg film-coated tablets, empagliflozin, Placebo matching empagliflozin, film-coated tablets
1245-0256
Phase 3 small_molecule active
Quick answer
Jardiance 10 mg film-coated tablets, empagliflozin, Placebo matching empagliflozin, film-coated tablets for Chronic kidney disease in paediatric patients is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Chronic kidney disease in paediatric patients
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active